1. neil2484
2. davichalfan9
3. gonefishinnow
4. lisamaree915
5. steh3587
1.moomoo7susan 02/21/2018
Sanford C. Bernstein reiterates Outperform rating; PT lowered to $60 from $71
2.davichalfan9 02/20/2018
Spark Therapeutics Reports 2017 Financial Results and Recent Business Progress
3.neil2484 01/26/2018
Licensing and Supply Agreement
4.steh3587 05/10/2018
Barclays raises price target to $85 from $64
5.neil2484 01/03/2018
News out!
6.gonefishinnow 02/21/2018
Stifel Nicolaus cuts PT to $64 from $73
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW